LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cryopreserved Erythrocytes Processed for Blood Transfusion

By LabMedica International staff writers
Posted on 10 Apr 2012
Cryostorage of red blood cells (RBCs) represents a valid alternative to liquid storage, since units can be preserved safely for at least a decade while conserving cell viability.

Preservation of blood for transfusion purposes has represented a lifesaving advance in clinical practice over many years, but although cryostorage has attracted a great deal of attention clinically, little is known about the biochemistry and physiology of cryostored erythrocyte concentrates.

Specialists at the University of Tuscia (Viterbo, Italy) investigated cryostorage of RBCs through monitoring of cell processing steps, from fresh blood, to glycerolization, thawing, and deglycerolization, followed by washing. Whole blood was collected from 10 healthy donor volunteers into 63 mL of citrate phosphate dextrose (CPD) anticoagulant, and leukodepleted. All glycerolized RBC units were frozen and stored at −80 ± 10 °C in a mechanical freezer for at least 12 months.

The erythrocytes were monitored through repeated assays of standard parameters of mean cell volume (MCV), red cell distribution width-standard deviation (RDW-SD), the mean cell hemoglobin concentration (MCHC), and the hematocrit (Hct). These were determined with a CA 530-Oden hematology analyzer. Scanning electron microscopy was also performed. Other standard biological indicators, such as hemoglobin content, pH values both internal and in the supernatant, lactate levels, osmotic fragility and hemolysis, were also calculated.

Cell processing for cryostorage resulted in increased RBC volumes. Mean cell volume (MCV) increased significantly upon glycerolization, from 89.4 ± 4.5 fL of fresh RBCs to 126.04 ± 2.3 fL of glycerolized RBCs, while it remained constant at 129.6 ± 3.3 fL upon cryostorage even after thawing. Deglycerolization and washing restored lower MCV values 93.7 ± 5.9 fL, though they were still higher than controls. Shape alterations caused an increase in osmotic fragility and permeability to ions. A significant pH drop was observed which could not to be attributed to a higher metabolic rate, since the levels of lactate did not show substantial fluctuation during the cell processing steps tested in this study. The membrane anomalies reported are likely related to the hemolysis observed which preferentially affected the densest and oldest cell sub-populations, as confirmed by means of discontinuous density gradients. The CA 530-Oden hematology analyzer used in the study is manufactured by Medonic (Stockholm, Sweden).

The authors concluded that their results indicate that cryostorage itself in presence of glycerol does not significantly affect RBCs. Most of the alterations observed were related to cell processing and, in particular, to the increase of cytosolic glycerol as a consequence of the glycerolization step. Further studies might profitably investigate replacing glycerol with nonpenetrating cryoprotectants such as polyvinylpyrrolidone or polyethylene glycol, or the less toxic sucrose and trehalose.The study was published online on March 14, 2012, in the journal Blood Cells, Molecules, and Diseases.

Related Links:

University of Tuscia
Medonic


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more